2018 annual financial data
Aytu BioPharma 2018 Net margin
Direct answer
Net margin was -278.36%.
Operating income was -19,700,234 USD and net income was -10,187,863 USD.
Operating cash flow was -15,940,322 USD.
Get free Aytu BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,660,000 USD
- Operating income
- -19,700,234 USD
- Net income
- -10,187,863 USD
- Operating cash flow
- -15,940,322 USD